Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2009
10/14/2009EP1646609B1 Novel chemiluminescent compounds and their use
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009EP1337527B1 Indolylmaleimide derivatives as protein kinase c inhibitors
10/14/2009CN101558062A Indolylmaleimide derivatives as kinase inhibitors
10/14/2009CN101558061A Process for preparing a crystalline form of candesartan cilexetil
10/14/2009CN101558059A Hepatitis C virus inhibitors
10/14/2009CN101558058A Modulators of CB1 receptors
10/14/2009CN101558055A Spiro substituted compounds as angiogenesis inhibitors
10/14/2009CN101558049A Substituted pyrazole and triazole compounds as KSP inhibitors
10/14/2009CN100549057C Low-viscosity polyisocyanate composition having high functionality and method for preparing same
10/14/2009CN100548992C Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
10/14/2009CN100548980C Isoindoline derivative
10/13/2009US7601836 Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7
10/13/2009US7601753 Pyrrolidine melanocortin-specific compounds
10/13/2009US7601750 Hydroxyalkylindole derivatives as anticancer agents; methyl [3-hydroxymethyl-2-(1-pentyl)-1-(2-phenylethyl)-5-methyl]indole-6-carboxylate, for example
10/13/2009US7601749 Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof
10/13/2009US7601748 Anti-androgenic pyrrolidines with tumor-inhibiting action
10/13/2009US7601745 Nuclear factor kappa beta (NF-kB) inhibitors such as [4-(1H-Indol-3-yl)-piperidin-1-yl]-{2-[1-(pyrazine-2-carbonyl)-piperidin-4-yl]-thiazol-4-yl}-methanone
10/13/2009US7601742 Pyrrolidones with anti-HIV activity
10/13/2009US7601730 Carboxylic acid derivatives, their preparation and use
10/13/2009US7601729 Matrix metalloproteinase inhibitors
10/13/2009US7601722 Gastrointestinal disorders; psychological disorders; neuropathic pain; cpgnition activators ; sexual disorders; chronic fatigue syndrome; sleep disorders; hyperactivity
10/13/2009US7601714 Pyrimidine derivatives useful as inhibitors of PKC-theta
10/13/2009US7601713 Kinase inhibitors and their uses
10/13/2009US7601435 Quinoxaline derivative, and organic semiconductor device, electric field light emitting device, and electronic device which have the same
10/13/2009CA2560510C N-(1-arylpyrazol-4yl) sulfonamides and their use as parasiticides
10/13/2009CA2473070C Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
10/13/2009CA2395866C Ophthalmic anti-allergy compositions suitable for use with contact lenses
10/13/2009CA2386974C Benzodiazepine derivatives for use in acute or chronic neurological disorders
10/13/2009CA2379666C Agent for preventing recurrence of cerebrovascular disorder and agent for ameliorating troubles following cerebrovascular disorder and inhibiting progress thereof
10/08/2009WO2009124167A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009WO2009124166A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009WO2009124037A1 Processes for preparing sunitinib and salts thereof
10/08/2009WO2009123967A1 5,6,7,8-tetrahydroquinazolin-2-amine derivatives and related compounds as histamine h4 receptor modulators for the treatment of asthma
10/08/2009WO2009123776A2 Antiviral drugs for treatment of arenavirus infection
10/08/2009WO2009123714A2 Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
10/08/2009WO2009123483A1 Process for preparation of telmisartan
10/08/2009WO2009123080A1 Indolinone compound
10/08/2009WO2009122180A1 Pyrimidine derivatives capable of inhibiting one or more kinases
10/08/2009WO2009122034A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/08/2009WO2009121910A1 Indene derivatives as estrogen receptor ligands
10/08/2009WO2009095792A3 Substituted heteroarylamide diazepinopyrimidone derivatives
10/08/2009US20090253908 Novel m3 muscarinic acetylchoine receptor antagonists
10/08/2009US20090253906 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
10/08/2009US20090253713 Small Molecule Compositions for Sexual Dysfunction
10/08/2009US20090253711 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
10/08/2009US20090253709 Synthesis, telomerase inhibition and cytotoxic studies on 2,7-disubstituted anthraquinone derivatives
10/08/2009US20090253705 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009US20090253697 Novel Indole Derivatives, Preparation Thereof as Medicinal Products and Pharmaceutical Compositions, and Especially as KDR Inhibitors
10/08/2009US20090253694 Fused hetrocyclic compounds
10/08/2009US20090253684 Leukotriene b4 inhibitors
10/08/2009US20090253682 Heterocyclic derivatives for modulation of calcium channels
10/08/2009US20090253678 Macrocyclic pyrimidine derivatives
10/08/2009US20090253676 Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of Diabetes
10/08/2009US20090253673 Substituted Pyrazoles as Ghrelin Receptor Antagonists
10/08/2009US20090253671 Tricyclic derivatives of azetidine and pyrrole with antibacterial activity
10/08/2009CA2720275A1 Indolinone compound
10/08/2009CA2720164A1 Processes for preparing sunitinib and salts thereof
10/08/2009CA2719876A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009CA2718488A1 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/08/2009CA2712071A1 Antiviral drugs for treatment of arenavirus infection
10/07/2009EP2106399A2 Imidazole derivatives as kinesin spindle protein inhibitors (eg-5)
10/07/2009EP1756087B1 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase
10/07/2009CN101553483A 2-(piperidin-4-yl)-4-phenoxy-or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors
10/07/2009CN101553481A Substituted sulfonamide derivatives
10/07/2009CN101553468A Organic compounds
10/07/2009CN101550132A Arylvinylazacycloalkane compounds and methods of preparation and use thereof
10/06/2009US7598383 mitogen activated protein kinase inhibitors; 4-(2-fluoro-4-methylphenylamino)-1,3-dimethyl-6,7-dihydro-1H-pyrrolo[3,4-b]pyridine-2,5-dione; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals
10/06/2009US7598360 Bisstyryl compound and high density recording media utilizing the same
10/06/2009US7598359 High density recording media with modified recording layers of the invention provides better photoelectrical performance; high recording sensitivity and high carrier-to-noise ratio
10/06/2009US7598288 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
10/06/2009US7598280 For the treatment, prevention and management of inflammatory and autoimmune diseases and disorders; for example, (1R,2S,3R)-1-(2-(5-methylisoxazol-3-yl)-1H-imidazol-5-yl)butane-1,2,3,4-tetraol
10/06/2009US7598272 Kinase inhibitors
10/06/2009US7598268 Vascular endothelial growth factor; tyrosine kinase inhibitor;angiogenesis inhibitor; anticarcinogenic agents
10/06/2009US7598260 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
10/06/2009US7598255 Pyrimidine compounds as serotonin receptor modulators
10/06/2009US7598251 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents
10/06/2009US7598250 for treating neurodegenerative disease such as Alzheimer's disease
10/06/2009US7598245 Pyruvate dehydrogenase kinase, c-KIT, cyclin-dependent kinases, Janus kinases, FLT3 kinase, AUR-2 kinase, tyrosine kinase; 1-(2-amino-4-pyridyl)-3-phenylaminotriazoles; combination therapy with antiallergens, immunomodulators, antiproliferative agents; Alzheimer's, Parkinson's, Multiple Sclerosis, asthma
10/06/2009US7598236 Diazabicyclic central nervous system active agents
10/06/2009US7597955 Light-emitting device, organic compound and display
10/01/2009WO2009121063A2 Chemokine receptor modulators
10/01/2009WO2009120660A2 Substituted pyridoxazines
10/01/2009WO2009120655A1 Indole derivatives
10/01/2009WO2009120094A2 Substituted pyrimidines and triazines and their use in cancer therapy
10/01/2009WO2009119880A1 Substituted pyrazole derivatives and use thereof
10/01/2009WO2009119776A1 Fused heterocyclic derivative and use thereof
10/01/2009WO2009119528A1 Heterocyclic compound
10/01/2009WO2009119088A1 Heterocyclic compound
10/01/2009WO2009118596A2 Phthalimide derivatives as trpa1 modulators
10/01/2009WO2009118305A1 Hydroxamate-based inhibitors of deacetylases b
10/01/2009WO2009118187A1 Methods for treating disorders using nmda nr2b-subtype selective antagonist
10/01/2009WO2009118175A1 Novel p2x7r antagonists and their use
10/01/2009WO2009118174A1 Substituted cyclohexyldiamines
10/01/2009WO2009117902A1 5-demethoxyfumagillol and derivatives thereof
10/01/2009WO2009117888A1 Phosphodiesterase iii inhibitors, preparation methods and medical uses thereof
10/01/2009WO2009095399A3 Pyrazine derivatives and their use as protein kinase inhbitors
10/01/2009WO2009080638A3 Sulfamides as zap-70 inhibitors
10/01/2009WO2009079797A9 Compounds and method for treatment of cancer
10/01/2009WO2009079767A9 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer
1 ... 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 ... 626